Interestingly, these studies have revealed that STZ-induced cerebral insulin deficiency in APP transgenic mice exacerbates the development of AD-like phenotypes such as β-amyloidosis and memory impairments [21]–[23]. The gene discussed is APP; the disease is Alzheimer disease.